The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2023

Filed:

Jun. 24, 2019
Applicant:

Emmetrope Ophthalmics Llc, Menlo Park, CA (US);

Inventors:

Jeffrey L. Goldberg, Menlo Park, CA (US);

Roger A. Goldberg, Menlo Park, CA (US);

Noelia J. Kunzevitzky, Menlo Park, CA (US);

Dillon Joseph Rak, Menlo Park, CA (US);

Assignee:

Emmetrope Ophthalmics LLC, Menlo Park, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61N 2/00 (2006.01); A61N 2/06 (2006.01); A61K 41/00 (2020.01);
U.S. Cl.
CPC ...
A61F 9/0008 (2013.01); A61K 41/00 (2013.01); A61N 2/00 (2013.01); A61N 2/06 (2013.01);
Abstract

In certain aspects, the invention is directed to magnetic eye shields that comprise a magnet. When worn by a patient, the magnetic eye shields are configured to generate an intraocular magnetic field of sufficient magnitude and direction to move a magnetic therapeutic and/or diagnostic agent positioned inside the eye to target tissue within the eye. Other aspects of the invention pertain to kits which comprise such magnetic eye shields as well as one or more additional components, for example, one or more containers of a magnetic diagnostic and/or or therapeutic agent. Further aspects of the invention pertain to methods of treatment, which comprise intraocularly introducing a magnetic therapeutic and/or diagnostic agent into an eye of a patient and fitting a magnetic eye shield to the head of the patient, wherein the magnetic therapeutic and/or diagnostic agent may be introduced to the patient before or after fitting the magnetic eye shield to the head of the patient.


Find Patent Forward Citations

Loading…